Partners

Clinical precision powered by radiomics & multi-modal AI

We empower our partners across the life-science sector to identify more patients and guide them to the right treatment at the right time
Book your demo
Optellum is trusted by industry & academic leaders
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University

Why partner with Optellum?

Commercial growth

BioPharmaMedTechDigital health
  • Patient discovery: Identify patients earlier and automatically, developing a funnel for finding more of the right patients.
  • Patient risk stratification: Optimize care decisions to guide procedures and increase opportunity for neoadjuvant and adjuvant treatments.
  • Patient acceleration: Accelerate diagnostic care pathway with discovery and prioritization of patients to shorten time to guideline-recommended treatment.

Patient discovery: Identify patients earlier and automatically, developing a funnel for finding more of the right patients.

Patient risk stratification: Optimize care decisions to guide procedures and increase opportunity for neoadjuvant and adjuvant treatments.1,2

Patient acceleration: Accelerate diagnostic care pathway with discovery and prioritization of patients to shorten time to guideline-recommended treatment.1,3

Clinical development

BioPharma
  • Patient enrollment: Identify the right patients and accelerate enrollment into clinical studies.
  • Predictive biomarkers RUO: Stratify patients earlier and more accurately to support precision care strategies.
  • Prognostic biomarkers RUO: Assess & monitor therapy response with robust biomarkers and automated volumetric quantification.

Patient enrollment: Identify the right patients and accelerate enrollment into clinical studies.1,4,5

Predictive biomarkers RUO: Stratify patients earlier and more accurately to support precision care strategies.6-9

Prognostic biomarkers RUO: Assess & monitor therapy response with robust biomarkers and automated volumetric quantification.6-10

Research collaboration

Academic
  • Biomarker & algorithm development: Co-develop cutting-edge image-based biomarkers for diagnosis and therapy guidance.
  • Study recruitment: Accelerated patient recruitment with image-based endpoints to reduce study participant numbers.
  • Clinical validation: Validate innovative care pathways and tools with cutting-edge image-based AI and radiomics.

Biomarker & algorithm development: Co-develop cutting-edge image-based biomarkers for diagnosis and therapy guidance.

Study recruitment: Accelerated patient recruitment with image-based endpoints to reduce study participant numbers.

Clinical validation: Validate innovative care pathways and tools with cutting-edge image-based AI and radiomics.

Data sharing

AcademicBioPharmaDigital healthMedTechProvider
  • Imaging & installation exchange: Use our clinical solutions at your provider sites in exchange for data.
  • Data licensing: Access our high-value imaging datasets with flexible licensing options.
  • Data enrichment: Enrich and integrate our data with yours for research and clinical applications.

Imaging & installation exchange: Use our clinical solutions at your provider sites in exchange for data.

Data licensing: Access our high-value imaging datasets with flexible licensing options.

Data enrichment: Enrich and integrate our data with yours for research and clinical applications.

Our services
Explore some examples of what we can do

Virtual Nodule Clinic Mass+

For Oncology partners

VNC with Tumor Dashboard discovers both lung nodules & masses, which may help clinicians to accelerate referral and prioritize candidates for neoadjuvant treatment.

Clinical USRUO UKRUO EU & EFTAOncology

LungRecur

Powered by LCP AI

Predict the risk of recurrence and support pre-procedural decisions on neo-adjuvant & peri-operative treatment.9

RUO USRUO UKRUO EU & EFTASurgeryOncology

Treatment optimization

Powered by LCP AI

Optimize treatment planning & monitoring for radioenhancer dosing & reliably assess treatment response.

RUO USRUO UKRUO EU & EFTAOncology
RUO = Research use only
Contact us
Certification
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
Contact us